REPRESENTATIVE EXPERIENCE
Pharma and BioPharma Litigation
Represented a developer of immunology and neurology medications in a patent license and breach of R&D contract action involving client's joint development with a peer of a treatment for ALS.
Defended a pharmaceutical manufacturer in a Hatch-Waxman patent infringement lawsuit filed by a competitor involving our client's paclitaxel product.
Represented multiple specialty pharmaceutical companies as plaintiffs in a Lanham Act false advertising lawsuit involving a competitor's alleged false advertising of its potassium chloride product.
Defended a manufacturer/developer of generic pharmaceuticals in a Hatch-Waxman patent infringement lawsuit filed by a competitor involving our client's posaconazole product.
Defended a manufacturer/developer of generic pharmaceuticals, and a specialty pharmaceutical manufacturer, in a Hatch-Waxman patent infringement lawsuit filed by a competitor involving a generic version of Namzaric.
Defended a manufacturer/developer of generic pharmaceuticals in a patent infringement lawsuit filed by a competitor involving our client's levothyroxine product.
Defended a manufacturer/developer of generic pharmaceuticals in a patent infringement lawsuit filed by a competitor involving our client's launch of a zoledronic acid product.
Defended a manufacturer/developer of generic pharmaceuticals in a Hatch-Waxman patent infringement lawsuit filed by a competitor involving our client's saxagliptin product.
Represented a manufacturer/developer of generic pharmaceuticals in a Lanham Act lawsuit involving a competitor's alleged false advertising of our client's vasopressin product.